Myocardial Postischemic Injury Is Reduced by PolyADPribose Polymerase-1 Gene Disruption

Abstract

PolyADPribosylation from PARP-1 and other sources of enzymatic PAR synthesis is associated with cardiac damage following myocardial ischemia. PARP inhibitors may have therapeutic utility in myocardial disease.